Jean De Serres

Board Member at Feldan Therapeutics

Dr. Jean De Serres currently serves as Vice President of Scientific Affairs and Operations at Paladin Labs

Dr. De Serres was previously CEO at Héma-Quebec, where he launched the production of stem cells, including the launch of a new plant. He was named Manager of the Year in 2003 for his success in cost efficiency and development. He is a former VP of R&D, Regulatory Affairs, and In-Licensing for Jubilant/Draximage/HolisterStier where he led the development and launch of products in imaging, oncology, and immunology.

Dr. De Serres contributed to the founding of various biotech companies, including MedDiscovery SA (2006), a Swiss firm developing new medications against urogenital cancers, as well as Biomilestones Inc. (2008) and Gestion BD, marketing consulting firms for biopharmaceuticals.

Dr. De Serres is a board member of MedDiscovery, and Cadens Medical Imaging, and has previously served on the board of multiple organizations such as BioQuebec, Montreal InVivo, and the Canadian College of Family Physicians.

From 1999 to 2005, he was Medical Director and General Manager at CSL Behring with sales mostly in hematology and immunology. From 1996 to 1999, he was Director of Public Health in the Ottawa area. He was previously in charge of teaching units at McGill University and was a practicing physician in emergency and family medicine.

In addition to his training in medicine, Dr. De Serres has a master’s degree in Community Health and an MBA in Bio-Industry Management from UQAM.